RecruitingNCT07108725

Non-invasive Diffusion-weighted Imaging With MRCP in the Diagnosis of Neoplastic Biliary Obstruction

The Role of Non-invasive Diffusion-weighted Imaging With MRCP in the Diagnosis of Neoplastic Biliary Obstruction

Sponsor

The General Authority for Teaching Hospitals and Institutes

Enrollment

100 participants

Start Date

May 1, 2025

Study Type

OBSERVATIONAL

Conditions

Diagnosis Non-invasive Diffusion-weighted Imaging Magnetic Resonance Cholangiopancreatography Neoplastic Biliary Obstruction

Summary

This study aims to evaluate the diagnostic value of non-invasive diffusion-weighted magnetic resonance imaging (DW-MRI) in detecting neoplastic biliary obstruction.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Magnetic Resonance Cholangiopancreatography for people with diagnosis, magnetic resonance cholangiopancreatography, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.